Diagnostichno Konsultativen Tsentar 1 Haskovo EOOD
- Address
- Ploshtad Gradska Bolnitsa 1, 6300 Haskovo, Bulgaria
Diagnostichno Konsultativen Tsentar 1 Haskovo EOOD - COPD Research Center
Diagnostichno Konsultativen Tsentar 1 Haskovo EOOD is a specialized medical research facility dedicated to advancing the understanding and treatment of Chronic Obstructive Pulmonary Disease (COPD). The center focuses on evaluating innovative therapeutic approaches for patients with symptomatic COPD, particularly those with a history of exacerbations requiring comprehensive management strategies.
- Triple combination therapy studies evaluating budesonide, glycopyrronium, and formoterol fumarate delivered via metered-dose inhalers
- Novel biologic therapies including tozorakimab as add-on treatments to standard COPD care
- Cardiopulmonary outcome assessments in COPD populations
- Exacerbation prevention strategies in former smokers with chronic respiratory disease
The center's research portfolio emphasizes comparative effectiveness trials that evaluate both dual bronchodilator therapies and advanced triple therapy combinations, with particular attention to reducing moderate to severe COPD exacerbations and improving overall cardiopulmonary health outcomes in this vulnerable patient population.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1AstraZeneca AB3active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB4trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Diagnostichno Konsultativen Tsentar 1 Haskovo EOOD
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicentre, Parallel-group, Phase IIb, Randomised, Double blind, Placebo-controlled, 4-Arm, 24-Week Study to Evaluate the Efficacy and Safety of AZD6793 Tablets in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (PRESTO). | AstraZeneca AB | Phase II | Recruiting | Sep 2025 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Salbutamol | 2 | Unknown | 2024-02-12 | 2024-07-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.